in organisms as diverse as plants, worms, flies, fish and mice 8 . Transposable elements became accessible for vertebrate genomics after the creation of Sleeping Beauty, a synthetic transposon generated from defective copies of an ancestral Tc1/mariner-like transposon in fish 9 . Mutagenesis screens in mammals established that transposable elements generate many random mutations in both mouse and rat germinal cells in vivo [10] [11] [12] [13] . This had been accomplished by breeding transgenic mice and rats that express the Sleeping Beauty transposase with animals that harbor the Sleeping Beauty transposon [10] [11] [12] [13] . This approach, however, does not permit one to preselect for transposition events that disrupt gene expression in the germline before producing mutant progeny. Alternatively, transposition events that disrupt gene expression in germline stem cells can be selected in tissue culture ( Fig. 1) , before being used to produce transgenic animals.
Here we took advantage of the unique biology of the spermatogonium, together with state-of-the-art transposon technology, to establish an experimental pipeline for knocking out genes in the rat (Supplementary Fig. 1 ). We carried out transposon mutagenesis in the rat germline by transfecting primary rat spermatogonial lines with a transposon plasmid containing a gene-trap selection cassette and a helper plasmid encoding an improved, hyperactive Sleeping Beauty transposase (Supplementary Fig. 2 ). We derived spermatogonial lines from individual transgenic Sprague Dawley rats that express EGFP specifically in the germline (germ cell-specific (GCS) EGFP rats) 2 . We clonally selected gene-trap insertions based on expression of the β-geo (comprising lacZ and neomycin resistance gene) construct from the trapped allele and based on G418 resistance (Fig. 1a) . We achieved a gene-trapping frequency of ~0.4% in the rat spermatogonia, which was fully dependent on transposase activity (Fig. 1b) . All G418-resistant spermatogonial colonies stained positive for β-galactosidase (Fig. 1b) . We defined over 150 Sleeping Beauty insertions from individually picked and expanded gene-trapped spermatogonial colonies by splinkerette PCR (Supplementary Table 1 ) and established 100 gene-trap events in genes distributed in 21 of the 22 rat chromosomes (Supplementary Fig. 3 ). Eight of these spermatogonial colonies contained disruptive exonic insertions, and 92 contained intronic gene-trap insertions (Supplementary Table 1 ). These results demonstrate the potential for Sleeping Beauty to disrupt a broad spectrum of genes in cultured rat spermatogonia.
To transmit stem cell genomes through the rat germline, we transplanted testes of sterile Dazl-deficient 14 and wild-type recipient rats with mixed populations of G418-resistant colonies selected as a polyclonal library. We estimated that the generated library contained ~2,400 individual spermatogonial clonal lines with trapped genes (gene-trapping frequency = 0. disrupting genes in the rat on a genome-wide scale will allow the investigation of many biological processes linked to human health. here we used transposon-mediated mutagenesis to knock out genes in rat spermatogonial stem cells. Given the capacity of the testis to support spermatogenesis from thousands of transplanted, genetically manipulated spermatogonia, this approach paves a way for high-throughput functional genomic studies in the laboratory rat.
Gene targeting in pluripotent embryonic stem cells has been especially successful for generating mice with specifically altered alleles to study disease processes in the whole mouse 1 . But cultured stem cells have not been used to modify genes in the germline of other mammalian species fundamental to biomedical research, such as the laboratory rat. Fortunately, advances in growing germline-competent stem cells, including spermatogonia 2,3 and embryonic stem cells 4,5 , offer new avenues for genomic manipulations in the rat.
The seminiferous epithelium of the rat testes provides a specialized niche that contains thousands of spermatogonial stem cells, which enable rats to produce millions of spermatozoa each day during peak reproductive capacity 6 . Rat spermatogonia can be grown in vitro under conditions in which they proliferate and maintain their potential to develop into spermatozoa when transplanted into testes of a compatible host 2,3 . Moreover, after transduction with lentiviral vectors, freshly isolated donor spermatogonia have been used to produce transgenic rats 7 . Thus, once transplanted into recipient testes, complex genomic libraries in mutant spermatogonial stem cells could theoretically facilitate large-scale production of genetically distinct mutant rats from only a small number of recipient founders (Supplementary Fig. 1 ).
Insertional mutagenesis using engineered transposable elements has proven to be one of the most productive and versatile strategies for disrupting and manipulating genes on a genome-wide scale showed clear development of β-galactosidase-positive spermatogonia (Fig. 1c) . We analyzed genotypes of rat progeny produced by crossing recipient males with wild-type females using PCR primers designed to detect the β-geo cassette in stably integrated Sleeping Beauty transposons, and the GCS EGFP rat transgene as an inheritable marker for the donor spermatogonial line (Supplementary Fig. 4) . We detected no donor-derived pups in litters born from a wild-type female and wild-type recipient pair (0/56 pups born; n = 6 litters) using the G418-selected spermatogonia (Supplementary Table 2 ). However, litters born from a wild-type female and Dazl-deficient recipient pair yielded 100% germline transmission of the GCS EGFP donor cell haplotype (113/113 pups born; n = 16 litters), in which the β-geo marker was transmitted to 72% (82/113 pups born) of the total F1 progeny, averaging 69.2 ± 29.7% GCS EGFP and β-geo-expressing pups per litter (mean ± s.d.; n = 16 litters) (Supplementary Table 2 ).
Because 100% of pups born were derived from donor spermatogonia (GCS EGFP + ), resulting Mendelian ratios (wild type:β-geo = 28:72; n = 113 F1 pups) for transmitting Sleeping Beauty to F1 progeny signified that multiple copies of the transposon integrated into stem spermatogonia during culture (Supplementary Fig. 5 ). We predicted gene-trap mutations to disrupt expression of at least 30 distinct genes upon analysis of the 82 Sleeping Beauty F1 mutant rats (~35%) (Supplementary Table 3) . Based on gene-specific probes for ten representative mutations (Igsf3, Ube2q2, RGD1561493 (similar to mouse Rgs22), Zmynd8 (also known as Prkcbp1), RGD1562674 (similar to mouse Ksr2), Arhgap26, Spaca6 (LOC688452), Ssbp2, Pclo and Pan3), trapped genes were stably transmitted from F1 mutant and wild-type breeders to F2 progeny, with 57 of 106 total F2 pups (~54%; n = 10 litters; 1 litter per mutant strain) inheriting their mutant parent's respective haplotype. Expression profiles for trapped genes were also transmitted to F2 progeny based on X-gal staining for β-geo expression in testes of neonatal Pan3 mutants and in Spaca6 mutant embryos (Fig. 1d,e) .
Next, we tested the sperm-forming potential of individually picked, G418-resistant spermatogonial colonies after transfecting cultures with the Sleeping Beauty gene-trap constructs and plating at low density. We expanded five colonies that stained strongest with X-gal to ~3 × 10 6 cells per culture. We cryopreserved portions of cells expanded from each colony and used them to define gene-trap insertions (Supplementary Table 1) . We transplanted remaining portions expanded from each colony into testes of one or two Dazl-deficient rats per colony. At 65-75 d after transplantation, we paired recipients with wild-type female rats, and 33% of breeder pairs produced viable litters expressing the donor cell haplotype (GCS EGFP + ) representing 40% of transplanted colonies (Supplementary Table 2) .
Spermatogonial colony 5 (SB5), which contained a gene-trap mutation in Slc35a3, resulted in mutant pups from one of two transplanted recipients (19 of 19 pups born) ( Supplementary  Fig. 6 ). Spermatogonial colony SB20, which contained gene-trap mutations in Tbc1d1, Ube2k (also known as Hip2 and E2-25k), Txndc13 and RGD1560888 (similar to mouse Cdk8), generated mutant pups from two of two transplanted recipients (50 of 50 pups born) (Supplementary Fig. 7 ). Germline transmission rates of defined gene-trap mutations in each colony demonstrated clear clonal enrichment in spermatogonial colonies picked after selection in G418-containing medium (Supplementary Figs. 6 and 7 and Supplementary Discussion).
Based on semiquantitative PCR analyses using primer sets to exonic regions that flank individual introns of Ube2k (Fig. 2a,b ) and northern blot analysis (Fig. 2c) , the relative levels of Ube2k transcripts in adult rat brain were reduced greater than 99% in rats homozygous for the Ube2k gene-trap mutation. Proteins encoded by the β-geo reporter were expressed ubiquitously in embryonic rats that inherited the Ube2k gene-trap mutation (Fig. 2d) . Accordingly, western blot analysis revealed that expression of the native UBE2K protein was effectively ablated in brains of adult rats homozygous for the Ube2k mutation (Supplementary Table 4 and Supplementary Fig. 8 ). Thus, rat spermatogonial stem cells can be genetically modified with Sleeping Beauty transposons in culture, clonally enriched for gene-trap mutations by selection in G418-containing medium and then used to produce knockout rats through natural breeding with recipient founders. By this approach, we generated 35 rat lines with defined genetrap mutations, in which greater than 50% of the trapped genes (Abca13, Alms1, Arntl, Btrc, RGD1560888 (similar to mouse Cdk8), Cdh17, Dlg1, Exoc6b, Fubp3, Grik3, RGD1562674 (similar to mouse Ksr2), Pclo, Zmynd8 (also known as Prkcbp1), RGD1561493 (similar to mouse Rgs22), Ssbp2, Slc35a3, Tmem57, Tbc1d1 and Ube2k) were associated with biological processes linked to an assortment of human diseases (Supplementary Table 3 ). The generated rat models are available as a resource at http://www4.utsouthwestern. edu/hamralab/knockout_rats.htm.
Since the advent of genetic manipulation of the mouse germline using cultures of pluripotent embryonic stem cells 1 , this, to our knowledge, is the initial report on using clonally selected germline stem cells from culture to disrupt genes in the rat (or in any mammalian species other than the mouse) 14 . Given the overarching popularity of the laboratory rat as a mammalian research model, an exciting prospect is to use stem cells of different epigenetic states (spermatogonia and embryonic stem cells) to broaden the spectrum of functional genomic elements that can be disrupted during mutagenesis screens. However, production of transgenic rats by injecting blastocysts with genetically manipulated cultures of embryonic stem cells remains an unsolved issue but appears feasible in the near future based on recent breakthroughs 4,5 . Nevertheless, by combining the repertoire of contemporary transposon systems available (Sleeping Beauty, Tol2 and piggyBac) 8, 15 to push the coverage of targetable transcribed genes to saturation in spermatogonial cultures, the ability to functionally annotate genes in the rat on a genome-wide scale becomes exceedingly more practical, both technologically and economically. online methods Transfection of spermatogonia and selection for gene trap insertions. Rat spermatogonial lines, RSGL-GCS3 and RSGL-GCS9, were derived using highly pure populations of undifferentiated spermatogonia isolated from the GCS EGFP transgenic line of Sprague Dawley rats 2, 16 . The GCS EGFP rat line expresses EGFP specifically during all stages of gametogenesis 17 . Spermatogonial line RSGL-GCS3 was thawed at passage 8 after cryo-storage in a spermatogonial medium (SG medium) containing 10% dimethyl sulfoxide (SG freezing medium) 16 and then expanded to passage 10 in fresh SG medium before collecting cells for nucleofection with Sleeping Beauty plasmids. Spermatogonial line RSGL-GCS9 was thawed at passage 9 after cryo-storage in SG freezing medium and then expanded to passage 11 in fresh SG medium before collecting for nucleofection with Sleeping Beauty plasmids. Collected spermatogonia were transfected with DNA test constructs using 10 μg total DNA in a suspension of 3 × 10 6 spermatogonia per 100 μl Nucleofection Solution L (Amaxa) using settings A020 on the Nucleofector (Amaxa). For genetic modification of the rat spermatogonial lines with a hyperactive Sleeping Beauty transposon/ transposase system, a 1:10 ratio of the transposase to transposon plasmids was used for transfections (1 μg transposase:9 μg transposon per 100 μl Nucleofection Solution L).
After transfection, the spermatogonia were plated directly into SG medium at an equivalent of ~2.5 × 10 5 nucleofected cells per 9.5 cm 2 onto freshly prepared irradiated mouse embryonic fibroblasts (MEFs) (a total of 3 × 10 6 cells from the nucleofection were plated into twelve 9.5 cm 2 wells of two 6-well culture dishes). On day 7 after nucleofection, cultures were maintained in SG medium containing 75 μg ml −1 G418 (Invitrogen) for an additional 10 d to select for cells that contained gene trap insertions. Cultures were fed fresh SG medium with G418 every 2 d. After this selection period, cultures were maintained in SG medium without G418. After nucleofection, fresh MEFs (2 × 10 4 cm −2 ) were added into ongoing cultures of spermatogonial colonies every 10-12 d before passaging. At 35-45 d after nucleofection, individual colonies were picked from cultures using a p200 Eppendorf tip and then the colonies were transferred into wells of a 96-well plate for monoclonal expansion of the germlines. In parallel, all of the colonies from the second six well plate from the same transfection using RSGL-GCS9 were collected and pooled for polyclonal expansion of rat germlines for an additional 35 d (after removing G418 from the culture medium) to sufficient numbers for both their cryopreservation (duplicate vials at 1-2 × 10 6 cells per line) in liquid nitrogen and for their transplantation into recipient rat testes as described below.
Spermatogonial transplantation. Wild-type and Dazl-deficient
Sprague Dawley rats were used as recipients for spermatogonial cultures 14 . Rats in the Dazl-deficient transgenic line are male-sterile because of a defect in spermatogenesis, but female rats from the same line remain fully fertile 18 . To prepare recipients for transplantation of spermatogonia, rats were injected intraperitoneally with 12 mg kg −1 busulfan using our established protocol 7, 19 . At 12 d after busulfan treatment of recipients, G418-resistant donor spermatogonia were collected from culture and loaded into injection needles at concentrations of 3-6 × 10 5 spermatogonia per 50 μl of culture medium containing 0.04% trypan blue (Sigma). The entire 50 μl volume was then transferred into the seminiferous tubules of anesthetized rats by retrograde injection through the rete of their right and left testis. Rats used for this study were housed as described 14 . Protocols for the use of rats in this study were approved by the Institutional Animal Care and Use Committee at University of Texas Southwestern Medical Center in Dallas, as certified by the Association for Assessment and Accreditation of Laboratory Animal Care International.
Plasmids and HeLa cell transfections. Sleeping Beauty transposons have a near-random genomic insertion profile with ~35% frequency for landing in a gene transcribed by RNA polymerase II 20 . As most hits in such genes are localized in introns, transposon insertions would normally not be mutagenic because they would be spliced from the primary transcript. Therefore, our Sleeping Beauty transposon was equipped with a 'gene-trap' cassette 21 , which reports both the insertion of the transposon into an expressed gene, and has a mutagenic effect by truncating the transcript through imposed splicing (Fig. 1a) . Gene trapping events only occur if orientation of the β-geo cassette coincides with that of the trapped gene and if splicing preserves the reading frame of the β-geo coding region. To generate the gene trap transposon vector, a 4.3-kb SA-β-geo-pA cassette consisting of a splice acceptor (SA-intron/exon2 boundary of adenovirus), lacZ-neomycin phosphotransferase fusion (β-geo) and polyadenylation signal from the bovine growth hormone gene was cut out of the pSAβ-geo vector 22 with XhoI. The ends were blunted with Klenow polymerase and ligated to SpeI linkers (NEB), and then the SA-β-geo-pA cassette was cloned into a Sleeping Beauty vector in which the left inverted repeat of the element had been doubled 23 . HeLa cells were seeded at a density of ~3 × 10 5 cells per well on 6-well plates 24 h before transfection. Plasmids containing transposon and transposase were transfected at ratios 1:1, 10:10, 1:10 and 10:1 (1 = 50 ng, 10 = 500 ng). Plasmid mixtures were adjusted to a total of 1 μg per transfection sample with FV4a-CAT plasmid, which expresses the chloramphenicol acetyl transferase under control of the carp beta-actin promoter and which lacks transposase activity. In the negative control, the transposase-containing plasmid was replaced with the same amount of a Caggs-CRE plasmid another transposase-deficient plasmid, which expresses CRE recombinase under control of the chicken beta-actin promoter and cytomegalovirus early enhancer. Transfection samples were prepared as 2 μl JetPEI-RGD (Polyplus Transfection) plus 98 μl 150 mM NaCl mix added to 100 μl plasmid per 150 mM NaCl mix. At 48 h after transfection, cells were trypsinized and 1/5 (200 μl of 1 ml suspension) of the cells from each transfected well were re-plated in 10-cm plates in medium containing G418 (0.6 mg ml −1 ) to initiate selection for cells containing gene-trap mutations. X-gal staining was done using a modified protocol 24 . Briefly, cells were washed with PBS, fixed for 5 min at 22-24 °C in 2% formaldehyde plus 0.2% glutaraldehyde in PBS and then rinsed with PBS and overlaid with the histochemical reaction mixture containing 1 mg ml −1 X-gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl 2 , 0.75 mM HCl and 0.1% Tween-20 in PBS and incubated at 37 °C for 24 h. After antibiotic selection, transposition efficiency was calculated from the numbers of G418-resistant cell colonies in the presence versus absence of the transposase.
PCR.
Splinkerette PCR was done as described 9 , by using a Csp6I restriction digest of the genomic DNA, and lacZ-specific primer pUC3 5′-cgattaagttgggtaacgccaggg-3′ and transposon inverted repeat-specific primer T-BalRev 5′-cttgtcatgaattgtgat acagtgaattataagtg-3′ in addition to the linker-specific primers. For reverse transcription PCR (RT-PCR), 5 μg DNaseI-treated RNA was reverse-transcribed using the lacZ-specific primer 5′-ttctgcttcatcagcaggatatcc-3′ and SuperScript III mRNA reverse transcriptase (Invitrogen). The single-stranded DNA was PCR-amplified using lacZ-specific primer lacZ2 5′-accacgc tcatcgataatttcacc-3′ and gene-specific primer Tbc1d1-P1 5′-atcacttgtgagcacgcagggaata-3′, and then amplified with nested primers ZRT 5′-gattgaccgtaatgggatagg-3′ and Tbc1d1-P2 5′-aagggaagggagggcatctagtcct-3′. PCR products were cloned into pGEM-T (Promega) and sequenced. Insertions that did not map to predicted genes were probably recovered from stem cell colonies with multiple transposon integrations that included at least a single gene-trap event (which is sufficient to confer a G418-resistant phenotype).
Real-time PCR was used to measure relative transcript abundance of trapped genes expressed in rat tissues. Total RNA was extracted from brain and skeletal muscle using the Trizol reagent (Ambion). The extracted RNA was quantified using the Pico-Green assay (Invitrogen). cDNA was synthesized by priming 100 ng total RNA from each tissue using random primers 2 . Relative levels of Ube2k and Tbc1D1 transcripts in tissues of each rat were then measured by semiquantitative PCR using SYBR green dye as described 2 . PCR primer sets for amplifying Ube2k cDNA fragments were designed to flank Ube2k introns 1, 4, 5 and to be specific for detecting cDNA encoding fragments of exon 3 and the 5′ untranslated region of exon 1 (Fig. 2 and 
Supplementary Table 5).
Genotyping mutant rat progeny. Genotyping primers were specific to the β-geo and GCS EGFP transgenes, and the LTR region of the lentiviral transgene used to produce the Dazldeficient rat line; primers to Gapdh were used to amplify loading controls (Supplementary Table 5 ). Gene-specific PCR primers near transposon integration sites that were predicted to disrupt gene expression in rats were used in combination with transposon-specific primers to genotype F1 and F2 progeny for newly generated mutant rat lines (Supplementary Table 5) . Genotyping results were verified by Southern blot hybridization assays of genomic DNA digested with XbaI using a probe specific for the Egfp transgenes and for olfactory marker protein gene (Omp) as a loading control, and the lacZ portion of the β-geo insert in the Sleeping Beauty transposon construct. The Egfp probe was isolated as a NheI-EcoRI fragment from pLEGFP-C1 (Clonetech). The Omp probe was isolated as a BamHI fragment from pTOPO-XL:Omp corresponding to base pairs 14268243-14269267 of NW_047561; GI:34857865; Rat Genome Sequencing Consortium version 3.4. Southern blot analysis of DNA isolated from representative F1 progeny derived from colonies SB5 and SB20 indicated that multiple transposons inserted into cells from each of these two colonies (Supplementary Fig. 5b ).
X-gal staining of rat tissues. Testes were dissected from rats and their seminiferous tubules were isolated free of the tunica albuginea. Isolated tubules were fixed for 40 min in 10 ml, 4% paraformaldehyde at 4 °C, rinsed 3 times for 30 min per rinse in 10 ml, 0.1 M phosphate buffer pH 7.3, 2 mM MgCl 2 , 0.01% sodium deoxycholate, 0.02% Nonidet P-40 at 4 °C, and then incubated for 4 h at 37 °C in X-gal staining solution containing 1 mg ml −1 X-gal in 0.1 M phosphate buffer pH 7.3, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide. After incubation in X-gal staining solution, seminiferous tubules were rinsed 3 times for 30 min each in 0.1 M phosphate buffer (pH 7.3). The same protocol was used for staining rat embryos isolated between embryonic day (E)14-E16, except that the isolated embryos were fixed using 0.2% glutaraldehyde in 0.1 M phosphate buffer (pH 7.3) with 2 mM MgCl 2 and 5 mM EGTA.
Northern blotting. Ten micrograms of total RNA isolated from adult rat brains using Trizol reagent was loaded onto a 1% agarose gel in glyoxal buffer and run using the NorthernMax-Gly kit (Applied Biosystems) and transferred to a BrightstarPlus Membrane (Applied Biosystems) according to manufacturer's protocol. The blot was hybridized with a probe to Actb (Applied Biosystems) or a probe generated to the Ube2k transcript complementary to base pairs 322-828 of reference sequence NM_ 001106006 (US National Center for Biotechnology Information identifier). The 506-bp Ube2k probe was amplified from wildtype rat brain cDNA using primers: 5′-cagaattaagaggagaaatag cagga-3′ and 5′-cagctcctgtgcctcagtta-3′. Radiolabeled probes were synthesized with the Rediprime II DNA Labeling System (GE Healthcare).
Western blotting. Protein extracts were prepared from brains of rat F2 litter mates produced from F1 parents that were each determined to be heterozygous for the gene-specific Ube2k Sleeping Beauty mutation after derivation from spermatogonial colony SB20. Protein extracts were prepared by homogenization of ~0.5 g of each collected tissue in 1.5 ml of ice-cold lysis buffer (50 mM HEPES (pH 8.0) 150 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton X-100, 10 μg ml −1 aprotinin, 10 μg ml −1 leupeptin and 1 protease inhibitor tablet in a 12.5 ml volume) for 30 s using a PTA-10 TS probe on setting 5 of a PT10-35 polytron (Kinematica). The homogenates were incubated on ice for 15-20 min and then centrifuged at 3,000g for 10 min at 4 °C in a GPR tabletop centrifuge (Beckman). The supernatant solutions were centrifuged at 15,800g for 10 min at 4 °C in a microcentrifuge (model 5042; Eppendorf), and the resultant supernatant fractions were then stored at −80 °C. Protein concentrations of each extract were determined by the BCA method (Pierce). Tissue extracts were diluted into NuPage LDS sample buffer containing NuPage Sample reducer according to manufacturer protocol (Invitrogen), and then fractionated (50 μg protein per lane) after loading into 10 well, Nupage 4-12% Bis-tris gels using MOPS running buffer with antioxidant (Invitrogen). Gels were transferred in the Invitrogen Xcell II Blot module (semi-wet apparatus) onto BA85 nitrocellulose, 30V for 1 h in NuPAge transfer buffer with antioxidant and 10% methanol. After transfer, nonspecific proteinbinding sites were blocked by incubating membrane blots overnight at 4 °C in blocking buffer: TBST-0.1% (Tris-buffered saline with 10 mM Tris-HCl (pH 7.5), 150 mM NaCl and 0.1% Tween-20) containing 5% nonfat dry milk. After blocking, blots were incubated with primary antibodies diluted in blocking buffer for 1 h at 22-24 °C. Mouse anti-GAPDH (IMG-5019A-2; IMGENEX) was diluted 1:500 and the mouse anti-beta-galactosidase (Z3783; Promega) was diluted 1:1000. Rabbit anti-UBE2K (3847; Cell Signaling) was diluted 1/1,000. Blots probed with the mouse primary antibodies
